Atlas Trials

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

Clinical trial NCT00967031 · COMPLETED

Trial details

NCT number
NCT00967031
Sponsor
UNICANCER
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastatic Cancer
Start date
2009-04-01
Primary completion
2012-02-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.